Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes

Published:2017-10-27 Issue:63 Volume:8 Page:106948-106961
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cedena M. Teresa¹²,Rapado Inmaculada¹²,Santos-Lozano Alejandro²³,Ayala Rosa¹²,Onecha Esther¹²,Abaigar María⁴,Such Esperanza⁵,Ramos Fernando⁶,Cervera José⁵⁷,Díez-Campelo María⁴⁸,Sanz Guillermo⁵,Rivas Jesús Hernández⁴⁸,Lucía Alejandro²⁹,Martínez-López Joaquin¹²

Affiliation:

1. Hematology Department, Hospital Universitario 12 Octubre, CNIO, Universidad Complutense, Madrid, Spain

2. Research Institute of Hospital 12 de Octubre (‘i+12’), Madrid, Spain

3. GIDFYS, European University Miguel de Cervantes, Valladolid, Spain

4. IBSAL, Cancer Research Center (USAL-CSIC), Salamanca, Spain

5. Hematology Department, Hospital Universitario La Fe, Valencia, Spain

6. Hematology Department, Hospital Universitario de León, and IBIOMED, Universidad León, León, Spain

7. Genetics Unit, Hospital Universitario La Fe, Valencia, Spain

8. Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain

9. Universidad Europea de Madrid, Madrid, Spain

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to Azacytidine in a Patient With Refractory Peripheral T-cell Lymphoma With TET2 Mutation;Cureus;2024-07-26

2. Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms;Blood Advances;2023-07-17

3. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes;Blood Advances;2023-04-26

4. IDH2 regulates U2AF1 expression and hydroxymethylation in MDS patients;Biotechnology and Genetic Engineering Reviews;2023-03-21

5. The Immuno-Oncology and Genomic Aspects of DNA-Hypomethylating Therapeutics in Acute Myeloid Leukemia;International Journal of Molecular Sciences;2023-02-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3